nVerses Capital’s CryoPort CYRX Stock Holding History

nVerses Capital’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,084	Closed	-$83.5K	–	353
2026 Q1	$83.5K	Buy	+10,084	New	+$91.1K	0.08%	329

Other funds holding CYRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

nVerses Capital's CYRX Position: Q2 2026 in Review

nVerses Capital sold out of CryoPort (CYRX) in Q2 2026, closing a stake of 10,084 shares — an estimated $83.5K sold.

nVerses Capital first reported a position in CYRX in Q1 2026 and held it in 1 quarter. The position peaked at $83.5K in Q1 2026. 128 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

nVerses Capital reported no remaining CryoPort position as of Q2 2026 after selling out during the quarter.
nVerses Capital sold 10,084 CryoPort shares in Q2 2026, an estimated $83.5K.
nVerses Capital first reported a position in CryoPort in Q1 2026 and held it in 1 quarter.
nVerses Capital's CryoPort position peaked at $83.5K in Q1 2026.
128 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.